3 results
Approved WMOCompleted
To assess the safety and tolerability of escalating single IV doses of NI-0801.To determine the pharmacokinetics and pharmacodynamics parameters of escalating single IV doses of NI-0801.
Approved WMOCompleted
Primary objective:Assesment of feasibility and toxicity of T cell depleted NMA Allo-SCT followed by lenalidomide or lenalidomide combined with bortezomib,and subsequent DLI; as treatment of relapsed multiple myeloma.Secondary objectives:To…
Approved WMOCompleted
The primary objective of this study will be:* To determine the overall response rate of KW-0761 for the treatment of patients with relapsed or refractoryPTCL;The secondary objectives of this study will be:* To determine the duration of response,…